EC 2.7.11.1 - ATP:protein phosphotransferase (non- specific) (non- specific serine/threonine protein kinase)

3D structures of EC 2.7.11.1 - non-specific serine/threonine protein kinase in Protein Data Bank

updated: 17 May 2012, 1:59

1. 3p1a: Structure of Human Membrane-associated Tyrosine- and Threonine- Specific Cdc2-inhibitory Kinase Myt1 (pkmyt1)
2. 3ow4: Discovery of Dihydrothieno- and Dihydrofuropyrimidines as Potent Pan Akt Inhibitors
3. 3ot8: X-ray Crystal Structure of Compound 17r Bound to Human Chk1 Kinase Domain
4. 3ot3: X-ray Crystal Structure of Compound 22k Bound to Human Chk1 Kinase Domain
5. 3op5: Human Vaccinia-related Kinase 1
6. 3omv: Crystal Structure of C-raf (raf-1)
7. 3og7: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx4032
8. 3o96: Crystal Structure of Human Akt1 with an Allosteric Inhibitor
9. 3o51: Crystal Structure of Anthranilamide 10 Bound to Auroraa
10. 3o50: Crystal Structure of Benzamide 9 Bound to Auroraa
11. 3ny5: Crystal Structure of The Rbd Domain of Serine/threonine-protein Kinase B-raf from Homo Sapiens. Northeast Structural Genomics Consortium Target HR4694F
12. 3nrm: Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitors
13. 3nkx: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
14. 3nay: Pdk1 in Complex with Inhibitor Mp6
15. 3nax: Pdk1 in Complex with Inhibitor Mp7
16. 3myg: Aurora a Kinase Complexed with Sch 1473759
17. 3mvh: Crystal Structure of Akt-1-inhibitor Complexes
18. 3mv5: Crystal Structure of Akt-1-inhibitor Complexes
19. 3mop: The Ternary Death Domain Complex of Myd88, Irak4, and Irak2
20. 3mn3: An Inhibited Conformation for The Protein Kinase Domain of The Saccharomyces Cerevisiae Ampk Homolog Snf1
21. 1mry: Crystal Structure of an Inactive Akt2 Kinase Domain
22. 3mfu: Cask-4m Cam Kinase Domain, Amppnp-mn2+
23. 3mft: Cask-4m Cam Kinase Domain, Mn2+
24. 3mfs: Cask-4m Cam Kinase Domain, Amppnp
25. 3mfr: Cask-4m Cam Kinase Domain, Native
26. 3mb7: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (amr)
27. 3mb6: Human Ck2 Catalytic Domain in Complex with a Difurane Derivative Inhibitor (cpa)
28. 3ma3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Naphtho-difuran Ligand
29. 3m9g: Crystal Structure of The Three-pasta-domain of a Ser/thr Kinase from Staphylococcus Aureus
30. 3m2w: Crystal Structure of Mapkak Kinase 2 (mk2) Complexed with a Spiroazetidine-tetracyclic Atp Site Inhibitor
31. 3lm5: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B) in Complex with Quercetin
32. 3lm0: Crystal Structure of Human Serine/threonine Kinase 17b (STK17B)
33. 3ll6: Crystal Structure of The Human Cyclin G Associated Kinase (gak)
34. 3lj2: Ire1 Complexed with Jak Inhibitor I
35. 3lj1: Ire1 Complexed with Cdk1/2 Inhibitor III
36. 3lj0: Ire1 Complexed with Adp and Quercetin
37. 3lau: Crystal Structure of Aurora2 Kinase in Complex with a GSK3BETA Inhibitor
38. 3kxn: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor Tetraiodobenzimidazole (k88)
39. 3kxm: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor K74
40. 3kxj: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68)
41. 3kxh: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor (2-dymethylammino-4,5,6,7-tetrabromobenzoimidazol-1yl- Acetic Acid (k66)
42. 3kxg: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Inhibitor 3,4,5,6,7-pentabromo-1h-indazole (k64)
43. 3kud: Complex of Ras-gdp with RAFRBD(A85K)
44. 3kuc: Complex of RAP1A(E30D/K31E)GDP with RAFRBD(A85K/N71R)
45. 3knb: Crystal Structure of The Titin C-terminus in Complex with Obscurin- like 1
46. 3kn6: Crystal Structure of The C-terminal Kinase Domain of Msk1
47. 3kn5: Crystal Structure of The C-terminal Kinase Domain of Msk1 in Complex with Amp-pnp
48. 3khf: The Crystal Structure of The Pdz Domain of Human Microtubule Associated Serine/threonine Kinase 3 (mast3)
49. 3kgv: Crystal Structure of Human Dna-dependent Protein Kinase Catalytic Subunit (dna-pkcs)
50. 3kga: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Potent 3-aminopyrazole Atp Site Inhibitor
51. 3kc3: Mk2 Complexed to Inhibitor N4-(7-(benzofuran-2-yl)-1h-indazol-5-yl) Pyrimidine-2,4-diamine
52. 3ka0: Mk2 Complex with Inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2- Hydroxyphenyl)-n-methylbenzo[b]thiophene-2-carboxamide
53. 3k5u: Identification, Sar Studies and X-ray Cocrystal Analysis of a Novel Furano-pyrimidine Aurora Kinase a Inhibitor
54. 3k21: Crystal Structure of Carboxy-terminus of PFC0420W.
55. 3k0e: Crystal Structure of The Phosphorylation-site Mutant T426N of The Kaic Circadian Clock Protein
56. 3k0c: Crystal Structure of The Phosphorylation-site Double Mutant S431A/T432E of The Kaic Circadian Clock Protein
57. 3k0a: Crystal Structure of The Phosphorylation-site Mutant S431A of The Kaic Circadian Clock Protein
58. 3k09: Crystal Structure of The Phosphorylation-site Mutant S431D of The Kaic Circadian Clock Protein
59. 3jzm: Crystal Structure of The Phosphorylation-site Mutant T432A of The Kaic Circadian Clock Protein
60. 3jya: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
61. 3jy0: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
62. 3jxw: Discovery of 3h-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioavailable Pim Kinases Inhibitors
63. 3jvs: Characterization of The Chk1 Allosteric Inhibitor Binding Site
64. 3jvr: Characterization of The Chk1 Allosteric Inhibitor Binding Site
65. 3juh: Crystal Structure of a Mutant of Human Protein Kinase CK2ALPHA with Altered Cosubstrate Specificity
66. 3jpv: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Pyrrolo[2,3-a]carbazole Ligand
67. 3ixe: Structural Basis of Competition between Pinch1 and Pinch2 for Binding to The Ankyrin Repeat Domain of Integrin-linked Kinase
68. 3iq7: Crystal Structure of Human Haspin in Complex with 5-iodotubercidin
69. 3iop: Pdk-1 in Complex with The Inhibitor Compound-8i
70. 3ion: Pdk1 in Complex with Compound 8h
71. 3ii5: The Complex of Wild-type B-raf with Pyrazolo Pyrimidine Inhibitor
72. 3iec: Helicobacter Pylori Caga Inhibits Par1/mark Family Kinases by Mimicking Host Substrates
73. 3idp: B-raf V600E Kinase Domain in Complex with an Aminoisoquinoline Inhibitor
74. 3i6w: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
75. 3i6u: Structure and Activation Mechanism of The Chk2 Dna-damage Checkpoint Kinase
76. 3hyh: Crystal Structure of The Protein Kinase Domain of Yeast Amp- Activated Protein Kinase Snf1
77. 3hrc: Crystal Structure of a Mutant of Human Pdk1 Kinase Domain in Complex with Atp
78. 3hdn: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 2
79. 3hdm: Crystal Structure of Serum and Glucocorticoid-regulated Kinase 1 in Complex with Compound 1
80. 3ha6: Crystal Structure of Aurora a in Complex with Tpx2 and Compound 10
81. 3h9o: Phosphoinositide-dependent Protein Kinase 1 (pdk-1) in Complex with Compound 9
82. 3h4j: Crystal Structure of Pombe Ampk Kdaid Fragment
83. 3h30: Crystal Structure of The Catalytic Subunit of Human Protein Kinase Ck2 with 5,6-dichloro-1-beta-d- Ribofuranosylbenzimidazole
84. 3h10: Aurora a Inhibitor Complex
85. 3h0z: Aurora a in Complex with a Bisanilinopyrimidine
86. 3h0y: Aurora a in Complex with a Bisanilinopyrimidine
87. 3gub: Crystal Structure of DAPKL93G Complexed with N6-(2- Phenylethyl)adenosine
88. 3gu8: Crystal Structure of DAPKL93G with N6-cyclopentyladenosine
89. 3gu7: Crystal Structure of DAPKQ23V-ADP-MG2+
90. 3gu6: Crystal Structure of DAPKQ23V-ADP
91. 3gu5: Crystal Structure of DAPKQ23V-AMPPNP-MG2+
92. 3gu4: Crystal Structure of DAPKQ23V-AMPPNP
93. 3gre: Crystal Structure of Saccharomyces Cerevisiae Vps15 Wd Repeat Domain
94. 3gok: Binding Site Mapping of Protein Ligands
95. 3ggf: Crystal Structure of Human Serine/threonine-protein Kinase Mst4 in Complex with an Quinazolin
96. 3g51: Structural Diversity of The Active Conformation of The N- Terminal Kinase Domain of P90 Ribosomal S6 Kinase 2
97. 3fyk: Crystal Structure of a Benzthiophene Lead Bound to Mapkap Kinase-2 (mk-2)
98. 3fyj: Crystal Structure of an Optimzied Benzothiophene Inhibitor Bound to Mapkap Kinase-2 (mk-2)
99. 3fy0: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Dw1
100. 3fxz: Crystal Structure of Pak1 Kinase Domain with Ruthenium Complex Lambda-fl172
101. 3fxw: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3/inhibitor 2 Complex
102. 3fwq: Inactive Conformation of Human Protein Kinase Ck2 Catalytic Subunit
103. 3fpq: Crystal Structure of The Kinase Domain of Wnk1
104. 3fpm: Crystal Structure of a Squarate Inhibitor Bound to Mapkap Kinase-2
105. 3fmd: Crystal Structure of Human Haspin with an Isoquinoline Ligand
106. 3fl5: Protein Kinase Ck2 in Complex with The Inhibitor Quinalizarin
107. 3fhr: High Resolution Crystal Structure of Mitogen-activated Protein Kinase-activated Protein Kinase 3 (mk3)-inhibitor Complex
108. 3fe3: Crystal Structure of The Kinase Mark3/par-1: T211A-S215A Double Mutant
109. 3fdn: Structure-based Drug Design of Novel Aurora Kinase a Inhibitors: Structure Basis for Potency and Specificity
110. 3fbv: Crystal Structure of The Oligomer Formed by The Kinase- Ribonuclease Domain of Ire1
111. 3f9n: Crystal Structure of Chk1 Kinase in Complex with Inhibitor 38
112. 3f6q: Crystal Structure of Integrin-linked Kinase Ankyrin Repeat Domain in Complex with Pinch1 Lim1 Domain
113. 3f69: Crystal Structure of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain in Complex with Kt5720
114. 3f61: Crystal Structure of M. Tuberculosis Pknb LEU33ASP/VAL222ASP Double Mutant in Complex with Adp
115. 3f5u: Crystal Structure of The Death Associated Protein Kinase in Complex with Amppnp and Mg2+
116. 3f5g: Crystal Structure of Death Associated Protein Kinase in Complex with Adp and Mg2+
117. 3f2n: Crystal Structure of Human Haspin with an Imidazo- Pyridazine Ligand
118. 3f2a: Crystal Structure of Human Pim-1 in Complex with Dappa
119. 3eha: Crystal Structure of Death Associated Protein Kinase Complexed with Amppnp
120. 3eh9: Crystal Structure of Death Associated Protein Kinase Complexed with Adp
121. 3efw: Structure of Auroraa with Pyridyl-pyrimidine Urea Inhibitor
122. 3e8d: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
123. 3e88: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
124. 3e87: Crystal Structures of The Kinase Domain of Akt2 in Complex with Atp-competitive Inhibitors
125. 3e7v: Crystal Structure of Human Haspin with a Pyrazolo- Pyrimidine Ligand
126. 3e7e: Structure and Substrate Recruitment of The Human Spindle Checkpoint Kinase Bub
127. 3e5a: Crystal Structure of Aurora a in Complex with Vx-680 and Tpx2
128. 3e3b: Crystal Structure of Catalytic Subunit of Human Protein Kinase CK2ALPHA Prime with a Potent Indazole-derivative Inhibitor
129. 3dvl: Crystal Structure of Full Length Circadian Clock Protein Kaic with Correct Geometry at Phosphorylation Sites
130. 3dlz: Crystal Structure of Human Haspin in Complex with Amp
131. 3dls: Crystal Structure of Human Pas Kinase Bound to Adp
132. 3dj7: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 130.
133. 3dj6: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 823.
134. 3dj5: Crystal Structure of The Mouse Aurora-a Catalytic Domain (asn186->gly, Lys240->arg, Met302->leu) in Complex with Compound 290.
135. 3dgk: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain
136. 3dfc: Crystal Structure of a Glycine-rich Loop Mutant of The Death Associated Protein Kinase Catalytic Domain with Amppnp
137. 3dcv: Crystal Structure of Human Pim1 Kinase Complexed with 4-(4- Hydroxy-3-methyl-phenyl)-6-phenylpyrimidin-2(1h)-one
138. 3dak: Crystal Structure of Domain-swapped Osr1 Kinase Domain
139. 3dae: Crystal Structure of Phosphorylated Snf1 Kinase Domain
140. 3d9v: Crystal Structure of Rock I Bound to H-1152p a Di- Methylated Variant of Fasudil
141. 3d6t: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
142. 3d4q: Pyrazole-based Inhibitors of B-raf Kinase
143. 1ul7: Solution Structure of Kinase Associated Domain 1 of Mouse Map/microtubule Affinity-regulating Kinase 3
144. 3d2k: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with [7-(2-{2-[3-(3-chloro- Phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3- D]pyrimidin-1-yl]-acetic Acid
145. 3d2i: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(1-methyl-1h- Pyrazolo[4,3-d]pyrimidin-7-ylamino)-ethyl]-thiazol-2-yl}-3- (3-trifluoromethyl-phenyl)-urea
146. 1unr: Crystal Structure of The Ph Domain of Pkb Alpha in Complex with a Sulfate Molecule
147. 3d15: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-(3-chloro-phenyl)-3- {5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- Ethyl]-thiazol-2- Yl}-urea [sns-314]
148. 3d14: Crystal Structure of Mouse Aurora a (asn186->gly, Lys240- >arg, Met302->leu) in Complex with 1-{5-[2-(thieno[3,2- D]pyrimidin-4-ylamino)-ethyl]- Thiazol-2-yl}-3-(3- Trifluoromethyl-phenyl)-urea
149. 3d0e: Crystal Structure of Human Akt2 in Complex with Gsk690693
150. 3cy3: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and The Jnk Inhibitor V
151. 3cy2: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand II
152. 3cxw: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Beta Carboline Ligand I
153. 3cu8: Impaired Binding of 14-3-3 to Raf1 Is Linked to Noonan and Leopard Syndrome
154. 3cqw: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
155. 3cqu: Crystal Structure of Akt-1 Complexed with Substrate Peptide and Inhibitor
156. 3com: Crystal Structure of Mst1 Kinase
157. 3coh: Crystal Structure of Aurora-a in Complex with a Pentacyclic Inhibitor
158. 3ckx: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24) in Complex with Staurosporine
159. 3ckw: Crystal Structure of Sterile 20-like Kinase 3 (mst3, Stk24)
160. 3c4e: Pim-1 Kinase Domain in Complex with 3-aminophenyl-7- Azaindole
161. 3c4d: B-raf Kinase V600E Oncogenic Mutant in Complex with Plx3203
162. 3c4c: B-raf Kinase in Complex with Plx4720
163. 3c13: Low Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
164. 3c0i: Cask Cam-kinase Domain- 3'-amp Complex, P212121 Form
165. 3c0h: Cask Cam-kinase Domain- Amppnp Complex, P1 Form
166. 3c0g: Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
167. 3bwf: Crystal Structure of The Human Pim1 in Complex with an Osmium Compound
168. 3bqr: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with an Imidazo-pyridazine Ligand
169. 3bqc: High Ph-value Crystal Structure of Emodin in Complex with The Catalytic Subunit of Protein Kinase Ck2
170. 3bhy: Crystal Structure of Human Death Associated Protein Kinase 3 (dapk3) in Complex with a Beta-carboline Ligand
171. 3bgz: Human Pim-1 Kinase in Complex with Diphenyl Indole Inhibitor Vx3
172. 3bgq: Human Pim-1 Kinase in Complex with an Triazolo Pyridazine Inhibitor Vx2
173. 3bgp: Human Pim-1 Complexed with a Benzoisoxazole Inhibitor Vx1
174. 3beg: Crystal Structure of Sr Protein Kinase 1 Complexed to Its Substrate Asf/sf2
175. 3be9: Structure-based Design and Synthesis of Novel Macrocyclic Pyrazolo[1,5-a] [1,3,5]triazine Compounds as Potent Inhibitors of Protein Kinase Ck2 and Their Anticancer Activities
176. 1wak: X-ray Structure of Srpk1
177. 3b43: I-band Fragment I65-i70 from Titin
178. 3akl: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
179. 3akk: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
180. 3akj: Crystal Structure of a Helicobacter Pylori Proinflammatory Kinase Ctka
181. 3aad: Structure of The Histone Chaperone Cia/asf1-double Bromodomain Complex Linking Histone Modifications and Site-specific Histone Eviction
182. 3a99: Structure of Pim-1 Kinase Crystallized in The Presence of P27KIP1 Carboxy-terminal Peptide
183. 3a62: Crystal Structure of Phosphorylated P70S6K1
184. 3a61: Crystal Structure of Unphosphorylated P70S6K1 (form Ii)
185. 3a60: Crystal Structure of Unphosphorylated P70S6K1 (form I)
186. 3a2c: Crystal Structure of a Pyrazolopyrimidine Inhibitor Complex Bound to Mapkap Kinase-2 (mk2)
187. 2zjw: Crystal Structure of Human Ck2 Alpha Complexed with Ellagic Acid
188. 2zej: Structure of The Roc Domain from The Parkinson's Disease- Associated Leucine-rich Repeat Kinase 2 Reveals a Dimeric Gtpase
189. 2z7s: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Purvalnol a
190. 2z7r: Crystal Structure of The N-terminal Kinase Domain of Human Rsk1 Bound to Staurosporine
191. 2z7q: Crystal Structure of The N-terminal Kinase Domain of Human Rsk-1 Bound to Amp-pcp
192. 2z6d: Crystal Structure of Lov1 Domain of Phototropin2 from Arabidopsis Thaliana
193. 2z6c: Crystal Structure of Lov1 Domain of Phototropin1 from Arabidopsis Thaliana
194. 2yza: Crystal Structure of Kinase Domain of Human 5'-amp- Activated Protein Kinase Alpha-2 Subunit Mutant (T172D)
195. 2yz0: Solution Structure of Rwd/gi Domain of Saccharomyces Cerevisiae Gcn2
196. 2ywp: Crystal Structure of Chk1 with a Urea Inhibitor
197. 2yub: Solution Structure of The Pdz Domain from Mouse Lim Domain Kinase
198. 2xru: Aurora-a T288E Complexed with Pha-828300
199. 2xng: Structure of Aurora-a Bound to a Selective Imidazopyrazine Inhibitor
200. 2xne: Structure of Aurora-a Bound to an Imidazopyrazine Inhibitor
201. 2xkf: Structure of Nek2 Bound to Aminopyrazine Compound 2
202. 2xke: Structure of Nek2 Bound to Aminipyrazine Compound 5
203. 2xkd: Structure of Nek2 Bound to Aminopyrazine Compound 12
204. 2xkc: Structure of Nek2 Bound to Aminopyrazine Compound 14
205. 2xk8: Structure of Nek2 Bound to Aminopyrazine Compound 15
206. 2xk7: Structure of Nek2 Bound to Aminopyrazine Compound 23
207. 2xk6: Structure of Nek2 Bound to Aminopyrazine Compound 36
208. 2xk4: Structure of Nek2 Bound to Aminopyrazine Compound 17
209. 2xk3: Structure of Nek2 Bound to Aminopyrazine Compound 35
210. 2xik: Structure of Human Ysk1 (yeast Sps1-ste20-related Kinase 1)
211. 2xh5: Structure of 4-(4-tert-butylbenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidin-4-amine Bound to Pkb
212. 2xf0: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
213. 2xez: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
214. 2xey: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
215. 2xck: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
216. 2xch: Crystal Structure of Pdk1 in Complex with a Pyrazoloquinazoline Inhibitor
217. 2x8i: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
218. 2x8e: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
219. 2x8d: Discovery of a Novel Class of Triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration
220. 2x81: Structure of Aurora a in Complex with Mln8054
221. 2x7g: Structure of Human Serine-arginine-rich Protein-specific Kinase 2 (srpk2) Bound to Purvalanol B
222. 2x7f: Crystal Structure of The Kinase Domain of Human Traf2- and Nck-interacting Kinase with WEE1CHK1 Inhibitor
223. 2x6e: Aurora-a Bound to an Inhibitor
224. 2x6d: Aurora-a Bound to an Inhibitor
225. 2x4z: Crystal Structure of The Human P21-activated Kinase 4 in Complex with Pf-03758309
226. 2x4f: The Crystal Structure of The Human Myosin Light Chain Kinase Loc340156.
227. 2x39: Structure of 4-amino-n-(4-chlorobenzyl)-1-(7h-pyrrolo(2,3-d) Pyrimidin-4-yl)piperidine-4-carboxamide Bound to Pkb
228. 2x18: The Crystal Structure of The Ph Domain of Human Akt3 Protein Kinase
229. 2x0g: X-ray Structure of a Dap-kinase Calmodulin Complex
230. 2wzj: Catalytic and Uba Domain of Kinase Mark2/(par-1) K82R, T208E Double Mutant
231. 2wwm: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex in Space Group P1
232. 2wwk: Crystal Structure of The Titin M10-obscurin like 1 Ig F17R Mutant Complex
233. 2wvi: Crystal Structure of The N-terminal Domain of Bubr1
234. 2wtw: Aurora-a Inhibitor Structure (2nd Crystal Form)
235. 2wtv: Aurora-a Inhibitor Structure
236. 2wtk: Structure of The Heterotrimeric LKB1-STRADALPHA-MO25ALPHA Complex
237. 2wtj: Crystal Structure of Chk2 in Complex with an Inhibitor
238. 2wti: Crystal Structure of Chk2 in Complex with an Inhibitor
239. 2wtd: Crystal Structure of Chk2 in Complex with an Inhibitor
240. 2wtc: Crystal Structure of Chk2 in Complex with an Inhibitor
241. 2wqo: Structure of Nek2 Bound to The Aminopyridine Cct241950
242. 2wqn: Structure of Adp-bound Human Nek7
243. 2wqm: Structure of Apo Human Nek7
244. 2wqe: Structure of S155R Aurora-a Somatic Mutant
245. 2wp3: Crystal Structure of The Titin M10-obscurin like 1 Ig Complex
246. 2wnt: Crystal Structure of The Human Ribosomal Protein S6 Kinase
247. 2wmx: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
248. 2wmw: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
249. 2wmv: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
250. 2wmu: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
251. 2wmt: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
252. 2wms: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
253. 2wmr: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
254. 2wmq: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
255. 2wiu: Mercury-modified Bacterial Persistence Regulator Hipba
256. 2wb8: Crystal Structure of Haspin Kinase
257. 2w7x: Cellular Inhibition of Checkpoint Kinase 2 and Potentiation of Cytotoxic Drugs by Novel Chk2 Inhibitor Pv1019
258. 2w7r: Structure of The Pdz Domain of Human Microtubule Associated Serine-threonine Kinase 4
259. 2w5h: Human Nek2 Kinase Apo
260. 2w5b: Human Nek2 Kinase Atpgammas-bound
261. 2w5a: Human Nek2 Kinase Adp-bound
262. 2w4k: X-ray Structure of a Dap-kinase 2-302
263. 2w4j: X-ray Structure of a Dap-kinase 2-277
264. 2w1g: Structure Determination of Aurora Kinase in Complex with Inhibitor
265. 2w1f: Structure Determination of Aurora Kinase in Complex with Inhibitor
266. 2w1e: Structure Determination of Aurora Kinase in Complex with Inhibitor
267. 2w1d: Structure Determination of Aurora Kinase in Complex with Inhibitor
268. 2w1c: Structure Determination of Aurora Kinase in Complex with Inhibitor
269. 2w0j: Crystal Structure of Chk2 in Complex with Nsc 109555, a Specific Inhibitor
270. 2vwi: Structure of The Osr1 Kinase, a Hypertension Drug Target
271. 2vuw: Structure of Human Haspin Kinase Domain
272. 2vu3: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
273. 2vtt: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
274. 2vts: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
275. 2vtr: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
276. 2vtq: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
277. 2vtp: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
278. 2vto: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
279. 2vtn: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
280. 2vtm: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
281. 2vtl: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
282. 2vtj: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
283. 2vti: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
284. 2vth: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
285. 2vrx: Structure of Aurora B Kinase in Complex with Zm447439
286. 2vki: Structure of The Pdk1 Ph Domain K465E Mutant
287. 2a38: Crystal Structure of The N-terminus of Titin
288. 2vgp: Crystal Structure of Aurora B Kinase in Complex with a Aminothiazole Inhibitor
289. 2vgo: Crystal Structure of Aurora B Kinase in Complex with Reversine Inhibitor
290. 2vd5: Structure of Human Myotonic Dystrophy Protein Kinase in Complex with The Bisindoylmaleide Inhibitor Bim VIII
291. 2v9j: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Mg.atp-amp
292. 2v92: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Atp-amp
293. 2v8q: Crystal Structure of The Regulatory Fragment of Mammalian Ampk in Complexes with Amp
294. 2v62: Structure of Vaccinia-related Kinase 2
295. 2v55: Mechanism of Multi-site Phosphorylation from a Rock-i:rhoe Complex Structure
296. 2v3s: Structural Insights into The Recognition of Substrates and Activators by The Osr1 Kinase
297. 2uzs: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
298. 2uzr: A Transforming Mutation in The Pleckstrin Homology Domain of Akt1 in Cancer (AKT1-PH_E17K)
299. 2uw9: Structure of Pkb-beta (akt2) Complexed with 4-(4-chloro- Phenyl)-4-(4-(1h-pyrazol-4-yl)-phenyl)-piperidine
300. 2uvm: Structure of Pkbalpha Ph Domain in Complex with a Novel Inositol Headgroup Surrogate, Benzene 1,2,3,4- Tetrakisphosphate
301. 2uv2: Crystal Structure of Human Ste20-like Kinase Bound to 4-(4-( 5-cyclopropyl-1h-pyrazol-3-ylamino)-quinazolin-2-ylamino)- Phenyl)-acetonitrile
302. 2uue: Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
303. 2rq8: Solution Nmr Structure of Titin I27 Domain Mutant
304. 2row: The C1 Domain of Rock II
305. 2rov: The Split Ph Domain of Rock II
306. 2rjm: 3ig Structure of Titin Domains I67-i69 E-to-a Mutated Variant
307. 2rio: Structure of The Dual Enzyme Ire1 Reveals The Basis for Catalysis and Regulation of Non-conventional Splicing
308. 2rik: I-band Fragment I67-i69 from Titin
309. 2r7i: Crystal Structure of Catalytic Subunit of Protein Kinase Ck2
310. 2r7b: Crystal Structure of The Phosphoinositide-dependent Kinase- 1 (pdk-1)catalytic Domain Bound to a Dibenzonaphthyridine Inhibitor
311. 2r5t: Crystal Structure of Inactive Serum and Glucocorticoid- Regulated Kinase 1 in Complex with Amp-pnp
312. 2r0u: Crystal Structure of Chek1 in Complex with Inhibitor 54
313. 2r0i: Crystal Structure of a Kinase Mark2/par-1 Mutant
314. 2qre: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with 5-aminoimidazole- 4-carboxamide 1-beta-d-ribofuranotide (zmp)
315. 2qrd: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Atp
316. 2qrc: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp and Amp
317. 2qr8: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2 (rsk2)
318. 2qr7: 2.0a X-ray Structure of C-terminal Kinase Domain of P90 Ribosomal S6 Kinase 2: Se-met Derivative
319. 2qr1: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase in Complex with Adp
320. 2qnj: Kinase and Ubiquitin-associated Domains of Mark3/par-1
321. 2qme: Crystal Structure of Human Rac3 in Complex with Crib Domain of Human P21-activated Kinase 1 (pak1)
322. 2qlv: Crystal Structure of The Heterotrimer Core of The S. Cerevisiae Ampk Homolog Snf1
323. 2qkw: Structural Basis for Activation of Plant Immunity by Bacterial Effector Protein Avrpto
324. 2qhn: Crystal Structure of Chek1 in Complex with Inhibitor 1a
325. 2qhm: Crystal Structure of Chek1 in Complex with Inhibitor 2a
326. 2cke: Human Death-associated Drp-1 Kinase in Complex with Inhibitor
327. 2qc6: Protein Kinase Ck2 in Complex with Dbc
328. 2cmw: Structure of Human Casein Kinase 1 Gamma-1 in Complex with 2-(2-hydroxyethylamino)-6-(3-chloroanilino)-9- Isopropylpurine (casp Target)
329. 2cn5: Crystal Structure of Human Chk2 in Complex with Adp
330. 2cn8: Crystal Structure of Human Chk2 in Complex with Debromohymenialdisine
331. 2q0n: Structure of Human P21 Activating Kinase 4 (pak4) in Complex with a Consensus Peptide
332. 2pzy: Structure of Mk2 Complexed with Compound 76
333. 2pzi: Crystal Structure of Protein Kinase Pkng from Mycobacterium Tuberculosis in Complex with Tetrahydrobenzothiophene Ax20017
334. 2pvr: Crystal Structure of The Catalytic Subunit of Protein Kinase Ck2 (c-terminal Deletion Mutant 1-335) in Complex with Two Sulfate Ions
335. 2pvn: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
336. 2pvm: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
337. 2pvl: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
338. 2pvk: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
339. 2pvj: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
340. 2pvh: Structure-based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase Ck2
341. 2pe2: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 3-{5-[2-oxo-5-ureido-1,2-dihydro- Indol-(3z)-ylidenemethyl]-1h-pyrrol-3-yl}-n-(2-piperidin-1- Yl-ethyl)-benzamide Complex
342. 2pe1: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) {2-oxo-3-[1-(1h-pyrrol-2-yl)-eth- (z)-ylidene]-2,3-dihydro-1h-indol-5-yl}-urea {bx-517} Complex
343. 2pe0: Crystal Structure of Human Phosphoinositide-dependent Protein Kinase 1 (pdk1) 5-hydroxy-3-[1-(1h-pyrrol-2-yl)- Eth-(z)-ylidene]-1,3-dihydro-indol-2-one Complex
344. 2p3g: Crystal Structure of a Pyrrolopyridine Inhibitor Bound to Mapkap Kinase-2
345. 2oza: Structure of P38ALPHA Complex
346. 2oxy: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
347. 2oxx: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole Derivatives K17, K22 and K32
348. 2oxd: Protein Kinase Ck2 in Complex with Tetrabromobenzoimidazole K17, K22 and K32 Inhibitors
349. 2ov2: The Crystal Structure of The Human Rac3 in Complex with The Crib Domain of Human P21-activated Kinase 4 (pak4)
350. 2ooy: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Atp
351. 2oox: Crystal Structure of The Adenylate Sensor from Amp- Activated Protein Kinase Complexed with Amp
352. 2onl: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
353. 2okr: Crystal Structure of The P38A-MAPKAP Kinase 2 Heterodimer
354. 2oid: Crystal Structure of Irak4 Kinase Domain Complexed with Amppnp
355. 2oic: Crystal Structure of Irak4 Kinase Domain Complexed with Staurosporine
356. 2oib: Crystal Structure of Irak4 Kinase Domain Apo Form
357. 2oi4: Crystal Structure of Human Pim1 in Complex with Fluorinated Ruthenium Pyridocarbazole
358. 2obj: Crystal Structure of Human Pim-1 Kinase in Complex with Inhibitor
359. 2o8y: Apo Irak4 Kinase Domain
360. 2dwb: Aurora-a Kinase Complexed with Amppnp
361. 2o65: Crystal Structure of Pim1 with Pentahydroxyflavone
362. 2o64: Crystal Structure of Pim1 with Quercetagetin
363. 2o63: Crystal Structure of Pim1 with Myricetin
364. 2o3p: Crystal Structure of Pim1 with Quercetin
365. 2nzi: Crystal Structure of Domains A168-a170 from Titin
366. 2nry: Crystal Structure of Irak-4
367. 2nru: Crystal Structure of Irak-4
368. 2e9n: Structure of H-chk1 Complexed with A767085
369. 2e9o: Structure of H-chk1 Complexed with Aa582939
370. 2e9p: Structure of H-chk1 Complexed with A771129
371. 2e9u: Structure of H-chk1 Complexed with A780125
372. 2e9v: Structure of H-chk1 Complexed with A859017
373. 2np8: Structural Basis for The Inhibition of Aurora a Kinase by a Novel Class of High Affinity Disubstituted Pyrimidine Inhibitors
374. 2ehb: The Structure of The C-terminal Domain of The Protein Kinase Atsos2 Bound to The Calcium Sensor Atsos3
375. 2l05: Solution Nmr Structure of The Ras-binding Domain of Serine/threonine- Protein Kinase B-raf from Homo Sapiens, Northeast Structural Genomics Consortium Target HR4694F
376. 2kui: Nmr Structure of The Pasta Domain of Mycobacterium Tuberculosis of Pknb
377. 2kuf: Nmr Structure of The Pasta Domain 3 and 4 of Mycobacterium Tuberculosis of Pknb
378. 2kue: Nmr Structure of The Pasta Domain 2 and 3 of Mycobacterium Tuberculosis of Pknb
379. 2kud: Nmr Structure of The Pasta Domain 1 and 2 of Mycobacterium Tuberculosis of Pknb
380. 2h34: Apoenzyme Crystal Structure of The Tuberculosis Serine/threonine Kinase, Pkne
381. 2h6d: Protein Kinase Domain of The Human 5'-amp-activated Protein Kinase Catalytic Subunit Alpha-2 (ampk Alpha-2 Chain)
382. 2h9v: Structural Basis for Induced-fit Binding of Rho-kinase to The Inhibitor Y27632
383. 2hak: Catalytic and Ubiqutin-associated Domains of Mark1/par-1
384. 2hog: Crystal Structure of Chek1 in Complex with Inhibitor 20
385. 2hw6: Crystal Structure of Mnk1 Catalytic Domain
386. 2hw7: Crystal Structure of MNK2-D228G in Complex with Staurosporine
387. 2hxl: Crystal Structure of Chek1 in Complex with Inhibitor 1
388. 2hxq: Crystal Structure of Chek1 in Complex with Inhibitor 2
389. 2hy0: Crystal Structure of Chek1 in Complex with Inhibitor 22
390. 2hy8: Pak1 Complex with St2001
391. 2i3s: Bub3 Complex with Bub1 Glebs Motif
392. 2ill: Anomalous Substructure of Titin-a168169
393. 2iwi: Crystal Structure of The Human Pim2 in Complex with a Ruthenium Organometallic Ligand Ru1
394. 2izr: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
395. 2izs: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
396. 2izt: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
397. 2izu: Structure of Casein Kinase Gamma 3 in Complex with Inhibitor
398. 2j0i: Crystal Structure of The Human P21-activated Kinase 4
399. 2j2i: Crystal Structure of The Humab Pim1 in Complex with Ly333531
400. 2j4z: Structure of Aurora-2 in Complex with Pha-680626
401. 2j50: Structure of Aurora-2 in Complex with Pha-739358
402. 2j51: Crystal Structure of Human Ste20-like Kinase Bound to 5- Amino-3-((4-(aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2,4-triazole-1-carbothioamide
403. 2j7t: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Su11274
404. 2j8h: Structure of The Immunoglobulin Tandem Repeat A168-a169 of Titin
405. 2j8o: Structure of The Immunoglobulin Tandem Repeat of Titin A168- A169
406. 2j90: Crystal Structure of Human Zip Kinase in Complex with a Tetracyclic Pyridone Inhibitor (pyridone 6)
407. 2jbo: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-1, Soaking)
408. 2jbp: Protein Kinase Mk2 in Complex with an Inhibitor (crystal Form-2, Co-crystallization)
409. 2jd5: SKY1P Bound to NPL3P-DERIVED Substrate Peptide
410. 2jdo: Structure of Pkb-beta (akt2) Complexed with Isoquinoline-5- Sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl) Amide
411. 2jdr: Structure of Pkb-beta (akt2) Complexed with The Inhibitor A- 443654
412. 2jfl: Crystal Structure of Human Ste20-like Kinase ( Diphosphorylated Form) Bound to 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-n-(2,6- Difluorophenyl)-1h-1,2, 4-triazole-1-carbothioamide
413. 2jfm: Crystal Structure of Human Ste20-like Kinase (unliganded Form)
414. 2jii: Structure of Vaccinia Related Kinase 3
415. 2jo8: Solution Structure of C-terminal Domain of Human Mammalian Sterile 20-like Kinase 1 (mst1)
416. 2jqi: Nmr Structure of The Rad53 Fha1 Domain in Complex with a Phosphothreonien Peptide Derived from Rad53 Scd1
417. 2jqj: Nmr Structure of Yeast Dun1 Fha Domain
418. 2jql: Nmr Structure of The Yeast Dun1 Fha Domain in Complex with a Doubly Phosphorylated (pt) Peptide Derived from Rad53 Scd1
419. 2kbx: Solution Structure of Ilk-pinch Complex
420. 2kio: Nmr Structure of The Oxidized Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 318k
421. 2kit: The Solution Struture of The Reduced Yeast Tor1 Fatc Domain Bound to Dpc Micelles at 298k
422. 3ncz: X-ray Co-structure of Rho-associated Protein Kinase (rock1) with a Potent 2h-isoquinolin-1-one Inhibitor
423. 3pa3: X-ray Crystal Structure of Compound 70 Bound to Human Chk1 Kinase Domain
424. 3pa4: X-ray Crystal Structure of Compound 2a Bound to Human Chk1 Kinase Domain
425. 3pa5: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
426. 3pm8: Cad Domain of PFF0520W, Calcium Dependent Protein Kinase
427. 2kr9: Kalirin Dh1 Nmr Structure
428. 2kty: Solution Structure of Human Vaccinia Related Kinase-1
429. 2kul: Solution Structure of Human Vaccinia Related Kinase 1(vrk1)
430. 2xbj: Crystal Structure of Chk2 in Complex with an Inhibitor
431. 2xix: Protein Kinase Pim-1 in Complex with Fragment-1 from Crystallographic Fragment Screen
432. 2xiy: Protein Kinase Pim-1 in Complex with Fragment-2 from Crystallographic Fragment Screen
433. 2xiz: Protein Kinase Pim-1 in Complex with Fragment-3 from Crystallographic Fragment Screen
434. 2xj0: Protein Kinase Pim-1 in Complex with Fragment-4 from Crystallographic Fragment Screen
435. 2xj1: Protein Kinase Pim-1 in Complex with Small Molecule Inibitor
436. 2xj2: Protein Kinase Pim-1 in Complex with Small Molecule Inhibitor
437. 2xm8: Co-crystal Structure of a Small Molecule Inhibitor Bound to The Kinase Domain of Chk2
438. 2xm9: Structure of a Small Molecule Inhibitor with The Kinase Domain of Chk2
439. 2y9r: Crystal Structure of The M10 Domain of Titin
440. 3nga: Human Ck2 Catalytic Domain in Complex with Cx-4945
441. 3nsz: Human Ck2 Catalytic Domain in Complex with Amppn
442. 3ofm: Structure of a Human CK2ALPHA Prime, The Paralog Isoform of The Catalytic Subunit of Protein Kinase Ck2 from Homo Sapiens
443. 3ose: Structure of The Kinase Associated Domain 1 (ka1) from Mark1 Kinase
444. 3osm: Structure of The Kinase Associated Domain-1 (ka1) from KCC4P
445. 3ost: Structure of The Kinase Associated-1 (ka1) from KCC4P
446. 3p23: Crystal Structure of The Human Kinase and Rnase Domains in Complex with Adp
447. 3pcs: Structure of Espg-pak2 Autoinhibitory Ialpha3 Helix Complex
448. 3ppj: Human B-raf Kinase in Complex with a Furopyridine Inhibitor
449. 3ppk: Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
450. 3prf: Crystal Structure of Human B-raf Kinase Domain in Complex with a Non- Oxime Furopyridine Inhibitor
451. 3pri: Crystal Structure of Human B-raf Kinase in Complex with a Non-oxime Furopyridine Inhibitor
452. 3ps4: Pdz Domain from Human Microtubule-associated Serine/threonine-protein Kinase 1
453. 3psb: Furo[2,3-c]pyridine-based Indanone Oximes as Potent and Selective B- Raf Inhibitors
454. 3pvg: Crystal Structure of Z. Mays Ck2 Alpha Subunit in Complex with The Inhibitor 4,5,6,7-tetrabromo-1-carboxymethylbenzimidazole (k68)
455. 3q4c: Crystal Structure of Wild Type Braf Kinase Domain in Complex with Organometallic Inhibitor Cns292
456. 3q5z: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain
457. 3q60: Crystal Structure of Virulent Allele ROP5B Pseudokinase Domain Bound to Atp
458. 3qf9: Crystal Structure of Human Proto-oncogene Serine Threonine Kinase (pim1) in Complex with a Consensus Peptide and a Furan- Thiazolidinedione Ligand
459. 2xnm: Structure of Nek2 Bound to Cct
460. 2xnn: Structure of Nek2 Bound to Cct242430
461. 2xno: Structure of Nek2 Bound to Cct243779
462. 2xnp: Structure of Nek2 Bound to Cct244858
463. 2y8l: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Two Adp
464. 2y8q: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with One Adp
465. 2y94: Structure of an Active Form of Mammalian Ampk
466. 2ya3: Structure of The Regulatory Fragment of Mammalian Ampk in Complex with Coumarin Adp
467. 2ya9: Crystal Structure of The Autoinhibited Form of Mouse Dapk2
468. 2yaa: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Atp
469. 2yab: Crystal Structure of The Autoinhibited Form of Mouse Dapk2 in Complex with Amp
470. 2yak: Structure of Death-associated Protein Kinase 1 (dapk1) in Complex with a Ruthenium Octasporine Ligand (osv)
471. 3aqv: Human Amp-activated Protein Kinase Alpha 2 Subunit Kinase Domain (T172D) Complexed with Compound C
472. 3m11: Crystal Structure of Aurora a Kinase Complexed with Inhibitor
473. 3m42: Crystal Structure of Mapkap Kinase 2 (mk2) Complexed with a Tetracyclic Atp Site Inhibitor
474. 3o0z: Crystal Structure of a Coiled-coil Domain from Human Rock I
475. 3orx: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Inhibitor 1f8
476. 3orz: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator 2a2
477. 3otu: Pdk1 Mutant Bound to Allosteric Disulfide Fragment Activator Js30
478. 3p9j: Aurora a Kinase Domain with Phthalazinone Pyrazole Inhibitor
479. 3pwy: Crystal Structure of an Extender (spd28345)-modified Human Pdk1 Complex 2
480. 3q96: B-raf Kinase Domain in Complex with a Tetrahydronaphthalene Inhibitor
481. 3qc4: Pdk1 in Complex with Dfg-out Inhibitor XXX
482. 3qcq: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-(3- Amino-1h-indazol-6-yl)-n4-ethyl-2,4-pyrimidinediamine
483. 3qcs: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-[2- Amino-6-(4-morpholinyl)-4-pyrimidinyl]-1h-indazol-3-amine
484. 3qcx: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 6-{2- Amino-6-[(3r)-3-methyl-4-morpholinyl]-4-pyrimidinyl}-1h-indazol-3- Amine
485. 3qcy: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 4-[2- Amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-n-phenyl-2- Morpholinecarboxamide
486. 3qd0: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with (2r,5s)- 1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4-pyrimidinyl]-6-methyl-n- Phenyl-3-piperidinecarboxamide
487. 3qd2: Crsytal Structure of Mouse Perk Kinase Domain
488. 3qd3: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl {(3r,6s)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-6-methyl-3-piperidinyl}carbamate
489. 3qd4: Phosphoinositide-dependent Kinase-1 (pdk1) Kinase Domain with 1,1- Dimethylethyl{(3r,5r)-1-[2-amino-6-(3-amino-1h-indazol-6-yl)-4- Pyrimidinyl]-5-methyl-3-piperidinyl}carbamate
490. 3qkk: Spirochromane Akt Inhibitors
491. 3qkl: Spirochromane Akt Inhibitors
492. 3qkm: Spirocyclic Sulfonamides as Akt Inhibitors
493. 2lav: Nmr Solution Structure of Human Vaccinia-related Kinase 1
494. 2lah: Solution Nmr Structure of Mitotic Checkpoint Serine/threonine-protein Kinase Bub1 N-terminal Domain from Homo Sapiens, Northeast Structural Genomics Consortium Target HR5460A (methods Development)
495. 3r00: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
496. 3r01: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
497. 3r02: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
498. 3r04: The Discovery of Novel Benzofuran-2-carboxylic Acids as Potent Pim-1 Inhibitors
499. 3lcy: Titin Ig Tandem Domains A164-a165
500. 3nlb: Novel Kinase Profile Highlights The Temporal Basis of Context Dependent Checkpoint Pathways to Cell Death
501. 3psd: Non-oxime Pyrazole Based Inhibitors of B-raf Kinase
502. 3r1n: Mk3 Kinase Bound to Compound 5b
503. 3r2b: Mk2 Kinase Bound to Compound 5b
504. 3r2y: Mk2 Kinase Bound to Compound 1
505. 3r30: Mk2 Kinase Bound to Compound 2
506. 2kyl: Solution Structure of Mast2-pdz Complexed with The C-terminus of Pten
507. 3rcj: Rapid Preparation of Triazolyl Substituted Nh-heterocyclic Kinase Inhibitors via One-pot Sonogashira Coupling Tms-deprotection Cuaac Sequence
508. 3rgx: Structural Insight into Brassinosteroid Perception by Bri1
509. 3rgz: Structural Insight into Brassinosteroid Perception by Bri1
510. 3riz: Crystal Structure of The Plant Steroid Receptor Bri1 Ectodomain
511. 3rj0: Plant Steroid Receptor Bri1 Ectodomain in Complex with Brassinolide
512. 3rp0: Structure of Human CK2ALPHA in Complex with a Non-hydrolysable Atp- Analogue and Magnesium Ions
513. 3rps: Structure of Human CK2ALPHA in Complex with The Atp-competitive Inhibitor 3-(4,5,6,7-tetrabromo-1h-benzotriazol-1-yl)propan-1-ol
514. 3s95: Crystal Structure of The Human Limk1 Kinase Domain in Complex with Staurosporine
515. 3sdj: Structure of Rnase-inactive Point Mutant of Oligomeric Kinase/rnase Ire1
516. 3sdm: Structure of Oligomeric Kinase/rnase Ire1 in Complex with an Oligonucleotide
517. 3r21: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
518. 3r22: Design, Synthesis, and Biological Evaluation of Pyrazolopyridine- Sulfonamides as Potent Multiple-mitotic Kinase (mmk) Inhibitors (part I)
519. 3skc: Human B-raf Kinase in Complex with an Amide Linked Pyrazolopyridine Inhibitor
520. 2yiq: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1322
521. 2yir: Structural Analysis of Checkpoint Kinase 2 in Complex with Inhibitor Pv1352
522. 2yit: Structural Analysis of Checkpoint Kinase 2 in Complex with Pv1162, a Novel Inhibitor
523. 3pe1: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-4945
524. 3pe2: Crystal Structure of Human Protein Kinase Ck2 in Complex with The Inhibitor Cx-5011
525. 3s1a: Crystal Structure of The Phosphorylation-site Double Mutant S431E/T432E of The Kaic Circadian Clock Protein
526. 3amy: Crystal Structure of Human Ck2 Alpha Complexed with Apigenin
527. 3t9i: Pim1 Complexed with a Novel 3,6-disubstituted Indole at 2.6 Ang Resolution
528. 3tac: Crystal Structure of The Liprin-alpha/cask Complex
529. 3tku: Mrck Beta in Complex with Fasudil
530. 3tv4: Human B-raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor
531. 3tv6: Human B-raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor
532. 3zut: The Structure of Ost1 (D160A) Kinase
533. 3zuu: The Structure of Ost1 (D160A, S175D) Kinase in Complex with Gold
534. 3p86: Crystal Structure of Ctr1 Kinase Domain Mutant D676N in Complex with Staurosporine
535. 3sc1: Novel Isoquinolone Pdk1 Inhibitors Discovered through Fragment-based Lead Discovery
536. 3si5: Kinetochore-bubr1 Kinase Complex
537. 2xuu: Crystal Structure of a Dap-kinase 1 Mutant
538. 3at2: Crystal Structure of CK2ALPHA
539. 3at3: Crystal Structure of CK2ALPHA with Pyradine Derivative
540. 3at4: Crystal Structure of CK2ALPHA with Pyradine Derivertive
541. 3pwd: Crystal Structure of Maize Ck2 in Complex with Nbc (z1)
542. 3t4n: Structure of The Regulatory Fragment of Saccharomyces Cerevisiae Ampk in Complex with Adp
543. 3tdh: Structure of The Regulatory Fragment of Sccharomyces Cerevisiae Ampk in Complex with Amp
544. 3te5: Structure of The Regulatory Fragment of Sacchromyces Cerevisiae Ampk in Complex with Nadh
545. 3zz2: Crystal Structure of Human Serine Threonine Kinase-10 Bound to Bosutinib
546. 2ycf: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1531
547. 2ycq: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv1115
548. 2ycr: Crystal Structure of Checkpoint Kinase 2 in Complex with Inhibitor Pv976
549. 2ycs: Crystal Structure of Checkpoint Kinase 2 in Complex with Pv788
550. 3rwp: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
551. 3rwq: Discovery of a Novel, Potent and Selective Inhibitor of 3- Phosphoinositide Dependent Kinase (pdk1)
552. 3tax: A Neutral Diphosphate Mimic Crosslinks The Active Site of Human O- Glcnac Transferase
553. 3udb: Crystal Structure of Snrk2.6
554. 2xzs: Death Associated Protein Kinase 1 Residues 1-312
555. 2y0a: Structure of Dapk1 Construct Residues 1-304
556. 3ppz: Crystal Structure of Ctr1 Kinase Domain in Complex with Staurosporine
557. 3puc: Atomic Resolution Structure of Titin Domain M7
558. 3pzh: Crystal Structure of Maize Ck2 Alpha in Complex with Emodin at 1.92 a Resolution
559. 3q04: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 8.5
560. 3q4z: Structure of Unphosphorylated Pak1 Kinase Domain
561. 3q52: Structure of Phosphorylated Pak1 Kinase Domain
562. 3q53: Structure of Phosphorylated Pak1 Kinase Domain in Complex with Atp
563. 3r0t: Crystal Structure of Human Protein Kinase Ck2 Alpha Subunit in Complex with The Inhibitor Cx-5279
564. 3she: Novel Atp-competitive Mk2 Inhibitors with Potent Biochemical and Cell- Based Activity throughout The Series
565. 3uc3: The Crystal Structure of Snf1-related Kinase 2.3
566. 3uc4: The Crystal Structure of Snf1-related Kinase 2.6
567. 4a06: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps114 Bound to The Pif-pocket
568. 4a07: Human Pdk1 Kinase Domain in Complex with Allosteric Activator Ps171 Bound to The Pif-pocket
569. 2y4v: Crystal Structure of Human Calmodulin in Complex with a Dap Kinase-1 Mutant (W305Y) Peptide
570. 4a55: Crystal Structure of P110ALPHA in Complex with Ish2 of P85ALPHA and The Inhibitor Pik-108
571. 2ym3: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
572. 2ym4: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
573. 2ym5: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
574. 2ym6: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
575. 2ym7: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
576. 2ym8: Crystal Structure of Checkpoint Kinase 1 (chk1) in Complex with Inhibitors
577. 3q9w: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 8.5
578. 3q9x: Crystal Structure of Human Ck2 Alpha in Complex with Emodin at Ph 6.5
579. 3q9y: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 8.5
580. 3q9z: Crystal Structure of Human Ck2 Alpha in Complex with Quinalizarin at Ph 6.5
581. 3qa0: Crystal Structure of The Apo-form of Human Ck2 Alpha at Ph 6.5
582. 3tl8: The Avrptob-bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains in a Single Type III Effector
583. 3uys: Crystal Structure of Apo Human CK1D
584. 3uyt: Crystal Structure of CK1D with Pf670462 from P1 Crystal Form
585. 3uzp: Crystal Structure of CK1D with Pf670462 from P21 Crystal Form
586. 2y4p: Dimeric Structure of Dapk-1 Catalytic Domain
587. 3qbn: Structure of Human Aurora a in Complex with a Diaminopyrimidine
588. 3uv5: Crystal Structure of The Tandem Bromodomains of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
589. 2ydj: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
590. 3u9n: X-ray Crystal Structure of Compound 1 Bound to Human Chk1 Kinase Domain
591. 3unz: Aurora a in Complex with Rpm1679
592. 3uo4: Aurora a in Complex with Rpm1680
593. 3uo5: Aurora a in Complex with Yl1-038-31
594. 3uo6: Aurora a in Complex with Yl5-083
595. 3uod: Aurora a in Complex with Rpm1693
596. 3uoh: Aurora a in Complex with Rpm1722
597. 3uoj: Aurora a in Complex with Rpm1715
598. 3uok: Aurora a in Complex with Yl5-81-1
599. 3uol: Aurora a in Complex with So2-162
600. 3up2: Aurora a in Complex with Rpm1686
601. 3up7: Aurora a in Complex with Yl1-038-09
602. 2lcs: Yeast NBP2P Sh3 Domain in Complex with a Peptide from STE20P
603. 3q5o: Crystal Structure of Human Titin Domain M10
604. 3ztx: Aurora Kinase Selective Inhibitors Identified Using a Taxol- Induced Checkpoint Sensitivity Screen.
605. 3v8s: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Indazole Derivative (compound 18)
606. 2ygv: Conserved N-terminal Domain of The Yeast Histone Chaperone Asf1 in Complex with The C-terminal Fragment of Rad53
607. 3qp3: Crystal Structure of Titin Domain M4, Tetragonal Form
608. 3tv7: Human Rho-associated Protein Kinase 1 (rock 1) in Complex with Rki1342
609. 3ujg: Crystal Structure of Snrk2.6 in Complex with Hab1
610. 4a7c: Crystal Structure of Pim1 Kinase with Etp46546
611. 4dit: Crystal Structure of GSK3BETA in Complex with a Imidazolopyridine Inhibitor
612. 3ua2: Crystal Structure of Circadian Clock Protein Kaic E318A Mutant
613. 2y9q: Crystal Structure of Human Erk2 Complexed with a Mapk Docking Peptide
614. 4a1g: The Crystal Structure of The Human Bub1 Tpr Domain in Complex with The Ki Motif of Knl1
615. 4afj: 5-aryl-4-carboxamide-1,3-oxazoles: Potent and Selective Gsk-3 Inhibitors
616. 2yer: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
617. 2yex: Synthesis and Evaluation of Triazolones as Checkpoint Kinase 1 Inhibitors
618. 3uv4: Crystal Structure of The Second Bromodomain of Human Transcription Initiation Factor Tfiid Subunit 1 (taf1)
619. 4daw: Crystal Structure of Pak1 Kinase Domain with The Ruthenium Phthalimide Complex
620. 4dug: Crystal Structure of Circadian Clock Protein Kaic E318A Mutant
621. 3vbq: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
622. 3vbt: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
623. 3vbv: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
624. 3vbw: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
625. 3vbx: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
626. 3vby: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
627. 3vc4: Exploitation of Hydrogen Bonding Constraints and Flat Hydrophobic Energy Landscapes in Pim-1 Kinase Needle Screening and Inhibitor Design
628. 2ydi: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
629. 2ydk: Discovery of Checkpoint Kinase Inhibitor Azd7762 by Structure Based Design and Optimization of Thiophene Carboxamide Ureas
630. 3axw: Crystal Structure of Human CK2ALPHA Complexed with a Potent Inhibitor
631. 3tkh: Crystal Structure of Chk1 in Complex with Inhibitor S01
632. 3tki: Crystal Structure of Chk1 in Complex with Inhibitor S25
633. 3uix: Crystal Structure of Pim1 Kinase in Complex with Small Molecule Inhibitor
634. 4af3: Human Aurora B Kinase in Complex with Incenp and Vx-680
635. 4aot: Crystal Structure of Human Serine Threonine Kinase-10 (lok) Bound to GW830263A
636. 4d9u: Rsk2 C-terminal Kinase Domain, (e)-tert-butyl 3-(4-amino-7-(3- Hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
637. 4dbn: Crystal Structure of The Kinase Domain of Human B-raf with a [1, 3]thiazolo[5,4-b]pyridine Derivative
638. 3rny: Crystal Structure of Human Rsk1 C-terminal Kinase Domain
639. 4a4x: Nek2-ede Bound to Cct248662
640. 4afe: Nek2 Bound to Hybrid Compound 21
641. 4apc: Crystal Structure of Human Nima-related Kinase 1 (nek1)
642. 4d9t: Rsk2 C-terminal Kinase Domain with Inhibitor (e)-methyl 3-(4-amino-7- (3-hydroxypropyl)-5-p-tolyl-7h-pyrrolo[2,3-d]pyrimidin-6-yl)-2- Cyanoacrylate
643. 3re4: Crystal Structure of Archaeoglobus Fulgidus Rio1 Kinase Bound to Toyocamycin.
644. 3vap: Synthesis and Sar Studies of Imidazo-[1,2-a]-pyrazine Aurora Kinase Inhibitors with Improved off Target Kinase Selectivity
645. 4anu: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
646. 4anv: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
647. 4anw: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
648. 4anx: Complexes of PI3KGAMMA with Isoform Selective Inhibitors.
649. 4aof: Selective Small Molecule Inhibitor Discovered by Chemoproteomic Assay Platform Reveals Regulation of Th17 Cell Differentiation by PI3KGAMMA
650. 4dgl: Crystal Structure of The Ck2 Tetrameric Holoenzyme
651. 4e26: Braf in Complex with an Organic Inhibitor 7898734
652. 4e4x: Crystal Structure of B-raf Kinase Domain in Complex with a Dihydropyrido[2,3-d]pyrimidinone-based Inhibitor
653. 4acc: GSK3B in Complex with Inhibitor
654. 4acd: GSK3B in Complex with Inhibitor
655. 4acg: GSK3B in Complex with Inhibitor
656. 4ach: GSK3B in Complex with Inhibitor
657. 4dk5: Crystal Structure of Human PI3K-GAMMA in Complex with a Pyridyl- Triazine Inhibitor
658. 4e7w: Structure of Gsk3 from Ustilago Maydis
659. 4eep: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2
660. 4eer: Crystal Structure of Lov2 Domain of Arabidopsis Thaliana Phototropin 2 C426A Mutant
661. 4ees: Crystal Structure of Ilov
662. 4eet: Crystal Structure of Ilov
663. 4eeu: Crystal Structure of Philov2.1